Trials / Completed
CompletedNCT00002223
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
Ritonavir (ABT-538)/Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavir/indinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy. This study also examines the safety and effectiveness of the ritonavir/indinavir combination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indinavir sulfate | |
| DRUG | Ritonavir |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2009-02-20
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002223. Inclusion in this directory is not an endorsement.